Comments on EPA Proposed Rule: Management Standards for Hazardous Waste Pharmaceuticals
Via: Regulations.gov: EPA–HQ–RCRA–2007–0932
Our organizations represent the interests of residents in long-term care facilities and other institutional practice settings, as well as the associated professionals who are committed to caring for the frailest of our citizens. We appreciate the opportunity to comment on the Environmental Protection Agency’s (EPA) proposed rule for handling hazardous waste pharmaceuticals.
The American Society of Consultant Pharmacists (ASCP) is pleased to submit comments on behalf of the undersigned organizations on the EPA’s proposed regulation on management standards for hazardous waste pharmaceuticals.
Summary:
We support efforts to ensure proper handling of hazardous waste pharmaceuticals (HWP) in the long- term care (LTC) setting. Our members are committed to take all reasonable steps to ensure the safety of the LTC residents that we serve and to protect the environment.
Our organizations do have a number of concerns with the proposed rule, such as the inclusion of assisted living facilities (ALF), continuing care retirement communities (CCRC), and nursing facilities (NF) in the definition of LTC facilities, expansion of responsibilities of the pharmacy staff, and its potential impact on the viability of small healthcare entities because of the increased compliance burden.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.